Information Technology·Electronic Components·$5.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.16 | N/A | -170.18% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.16 | N/A | -170.18% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Overall, management conveyed a cautious outlook, emphasizing the difficulties faced in the current economic environment.
Management expressed concerns about current market conditions.
They highlighted challenges in demand affecting performance.
Belden Inc's disappointing EPS result indicates ongoing challenges within the company, likely due to weak demand. The stock fell 4.74% in response, reflecting investor concerns about future performance. Without any guidance provided, uncertainty remains about the company's direction in the upcoming quarters.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Oct 26, 2009